Lars B. Abrahmsen

SVP, Chief Scientific Officer, Aprea Therapeutics, Inc.

Companies

Aprea Therapeutics, Inc.SVP, Chief Scientific Officer Oct 2, 2019 to Mar 14, 2022¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aprea Therapeutics, Inc. APRE43,700 shares²$24.7K at $0.56Mar 10, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 10, 2022Granted 24,700 shares of Aprea Therapeutics, Inc.²
Oct 1, 2021Sold 50,000 shares at $4.89 of Aprea Therapeutics, Inc.³
Oct 1, 2021Exercised options 50,000 shares at $0.92 of Aprea Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAprea Therapeutics, Inc., SVP, Chief Scientific Officer
2
SEC EDGARAprea Therapeutics, Inc. shares after the filing of Mar 10, 2022
3
SEC EDGARForm 4 filed Oct 5, 2021